Xenotransplantation: Finally Close to the Clinic?
The transplantation of organs and cells from pigs (xenotransplantation) holds great promise for the treatment of a range of human medical conditions, including type 1 diabetes, kidney disease and heart failure. However, clinical application remains elusive due to the complexity of the immune response to transplanted porcine tissue. In his talk, Peter Cowan highlights recent breakthroughs in preclinical models and the prospect for clinical trials in the near future. He also discusses the increasing importance of gene editing of the donor pig.
Peter Cowan ist wissenschaftlicher Direktor des Immunology Research Centre des St. Vincent`s Hospital in Melbourne und derzeit Visiting Fellow am CAS.
Ort und Anmeldung
Gene Center Munich, Feodor-Lynen- Straße 25 // Lynen Lecture Hall (A 0.75), 81377 München